< Back to all Breaking News
IKT
8/26/2022 08:08am
Inhibikase Therapeutics' NDA for chronic myelogenous leukemia cleared by FDA 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
